Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

Therapeutic targets have been defined for axial and peripheral spondyloarthritis (SpA) in 2012, but the evidence for these recommendations was only of indirect nature. These recommendations were re-evaluated in light of new insights. Based on the results of a systematic literature review and expert...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Smolen, JS, Schöls, M, Braun, J, Dougados, M, FitzGerald, O, Gladman, DD, Kavanaugh, A, Landewé, R, Mease, P, Sieper, J, Stamm, T, Wit, MD, Aletaha, D, Baraliakos, X, Betteridge, N, Bosch, FVD, Coates, LC, Emery, P, Gensler, LS, Gossec, L, Helliwell, P, Jongkees, M, Kvien, TK, Inman, RD, McInnes, IB, Maccarone, M, Machado, PM, Molto, A, Ogdie, A, Poddubnyy, D, Ritchlin, C, Rudwaleit, M, Tanew, A, Thio, B, Veale, D, Vlam, KD, van der Heijde, D
פורמט:	Journal article
שפה:	English
יצא לאור:	BMJ Publishing Group 2017

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

פריטים דומים